Powered by Data

Episode 2: Global Transparency

In Episode 2, our panel takes on one of the most complex compliance challenges facing Life Sciences: reporting transparency obligations across a global footprint. Scott McLean (Executive Director, Sales), Cristina List, CPA, CCEP (Director — Global Regulations and Report Development), Tenille Goodman (Compliance Advisor) and Jared Esposito (Vice President — Product) unpack why U.S. Federal Open Payments (Sunshine Act) is often mistaken as the global standard and what companies actually face once they operate across multiple jurisdictions.

The conversation explores surprising nuances, from Oregon and Connecticut’s zero-dollar interaction reporting to France’s disclosure of agreements, Belgium’s calendar-year lookback triggered by global commercial authorization and Italy’s forthcoming date and place of birth requirement. The panel also examines why GDPR, consent, legitimate interest and the right to be forgotten have fundamentally reshaped how transparency data must be managed.

“When people look at this as a single comprehensive problem that everyone needs to work on, that’s when organizations are better off.” – Jared Esposito

The panel closes with a practical view of why successful global programs are built intentionally and scaled thoughtfully, starting with a single country and expanding from there.